SYTL4
Basic information
Region (hg38): X:100671783-100732123
Links
Phenotypes
GenCC
Source:
- retinal disorder (Limited), mode of inheritance: XL
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SYTL4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 35 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 35 | 3 | 0 |
Variants in SYTL4
This is a list of pathogenic ClinVar variants found in the SYTL4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-100676045-G-T | not specified | Uncertain significance (Dec 01, 2022) | ||
X-100676068-T-G | not specified | Uncertain significance (Feb 07, 2023) | ||
X-100676079-T-C | Likely benign (Jan 01, 2023) | |||
X-100676113-T-A | not specified | Uncertain significance (Sep 02, 2024) | ||
X-100678480-T-C | not specified | Uncertain significance (Sep 10, 2024) | ||
X-100678543-T-C | not specified | Uncertain significance (Jun 19, 2024) | ||
X-100678561-T-G | not specified | Uncertain significance (Nov 25, 2024) | ||
X-100678565-G-A | not specified | Uncertain significance (May 07, 2024) | ||
X-100678577-T-C | not specified | Uncertain significance (Nov 29, 2024) | ||
X-100678589-G-A | not specified | Uncertain significance (Nov 26, 2024) | ||
X-100679355-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
X-100679356-T-A | not specified | Uncertain significance (Apr 11, 2023) | ||
X-100679401-C-T | Likely benign (Mar 01, 2023) | |||
X-100681236-G-A | not specified | Uncertain significance (Dec 13, 2024) | ||
X-100681308-G-A | not specified | Uncertain significance (Apr 04, 2024) | ||
X-100681319-G-A | not specified | Likely benign (Aug 20, 2023) | ||
X-100681326-C-T | not specified | Uncertain significance (May 16, 2023) | ||
X-100685997-T-C | not specified | Uncertain significance (Feb 07, 2025) | ||
X-100686074-G-C | not specified | Uncertain significance (Nov 23, 2024) | ||
X-100686087-C-T | not specified | Uncertain significance (Feb 14, 2025) | ||
X-100686088-G-A | not specified | Uncertain significance (Oct 27, 2022) | ||
X-100686110-C-A | not specified | Uncertain significance (Feb 25, 2025) | ||
X-100686155-T-C | Likely benign (Nov 01, 2022) | |||
X-100686686-G-A | not specified | Uncertain significance (Jan 03, 2025) | ||
X-100686747-G-A | not specified | Uncertain significance (Feb 15, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SYTL4 | protein_coding | protein_coding | ENST00000455616 | 16 | 57623 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0141 | 0.986 | 125701 | 10 | 26 | 125737 | 0.000143 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.812 | 222 | 259 | 0.858 | 0.0000204 | 4430 |
Missense in Polyphen | 70 | 94.865 | 0.73789 | 1587 | ||
Synonymous | 2.15 | 65 | 91.1 | 0.713 | 0.00000661 | 1255 |
Loss of Function | 3.21 | 8 | 25.5 | 0.314 | 0.00000191 | 444 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000528 | 0.000528 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000223 | 0.000149 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000597 | 0.0000327 |
Other | 0.000955 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Modulates exocytosis of dense-core granules and secretion of hormones in the pancreas and the pituitary. Interacts with vesicles containing negatively charged phospholipids in a Ca(2+)-independent manner (By similarity). {ECO:0000250}.;
- Pathway
- Deregulation of Rab and Rab Effector Genes in Bladder Cancer;Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- loftool
- 0.729
- rvis_EVS
- 0.26
- rvis_percentile_EVS
- 70.44
Haploinsufficiency Scores
- pHI
- 0.304
- hipred
- Y
- hipred_score
- 0.726
- ghis
- 0.505
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.524
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sytl4
- Phenotype
- homeostasis/metabolism phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- platelet degranulation;intracellular protein transport;positive regulation of exocytosis;negative regulation of insulin secretion;positive regulation of protein secretion;multivesicular body sorting pathway
- Cellular component
- nucleoplasm;endosome;microtubule organizing center;cytosol;plasma membrane;extrinsic component of membrane;transport vesicle membrane;platelet alpha granule membrane;exocytic vesicle
- Molecular function
- protein binding;phospholipid binding;Rab GTPase binding;neurexin family protein binding;metal ion binding